Showing results (71-80 of 107) with videos related to
Sort By:
Pageof 11
Journal of Affective Disorders|February 1, 1993
DSM-III-R personality disorders in a mood and anxiety disorders clinic: prevalence, comorbidity, and clinical correlatesS N Flick, P P Roy-Byrne, D S Cowley, et al.Biological Psychiatry|July 1, 1991
Lactate vulnerability after alprazolam versus placebo treatment of panic disorderD S Cowley, S R Dager, P P Roy-Byrne, et al.Psychiatry Research|March 1, 1988
Ventricular-brain ratio and life course of illness in patients with affective disorderP P Roy-Byrne, R M Post, C H Kellner, et al.Journal of Anxiety Disorders|June 27, 2000
Psychiatric diagnoses among self-referred dental injection phobicsT Kaakko, S E Coldwell, T Getz, et al.Biological Psychiatry|January 1, 1987
Platelet [3H]imipramine binding in patients with panic disorderT W Uhde, W H Berrettini, P P Roy-Byrne, et al.SAR and QSAR in Environmental Research|November 19, 2025
A computational-based search of natural product derived multi-target ligands for the management of Alzheimer's and Parkinson's disease using structure-based pharmacophore modelling, virtual screening, MD docking, free energy analysis, ADMET profiling and DFT studiesN Chhabra, B W Matore, A Murmu, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 21, 1998
Does ketamine-mediated N-methyl-D-aspartate receptor antagonism cause schizophrenia-like oculomotor abnormalities?A D Radant, T A Bowdle, D S Cowley, et al.Journal of Affective Disorders|July 1, 1988
Suicide and course of illness in major affective disorderP P Roy-Byrne, R M Post, D D Hambrick, et al.The American Journal of Psychiatry|March 21, 1998
Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatientsA J Elliott, K K Uldall, K Bergam, et al.Psychopharmacology|January 1, 1987
Effects of diazepam on cognitive processes in normal subjectsP P Roy-Byrne, T W Uhde, H Holcomb, et al.Pageof 11